Stock SAGE SAGE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Sage Therapeutics, Inc.

Equities

SAGE

US78667J1088

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-17 pm EDT 		5-day change 1st Jan Change
11.7 USD -2.58% Intraday chart for Sage Therapeutics, Inc. -1.68% -46.01%
May. 15 Transcript : Sage Therapeutics, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 10:00 AM
Apr. 25 Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
SAGE THERAPEUTICS, INC. Stock Sage Therapeutics, Inc.
 704M -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
ARGENX SE Stock argenx SE
 21.96B -
BIONTECH SE Stock BioNTech SE
 21.87B -
GENMAB A/S Stock Genmab A/S
 19.21B
  1. Stock Market
  2. Equities
  3. SAGE Stock
  4. Charts Sage Therapeutics, Inc.
  5. Sector Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW